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4orf6 plays an important role in the transportation
of cellular and viral mRNAs and is known as an
oncogene product of adenovirus. Here, we show
that E4orf6 interacts with pp32/leucine-rich acidic nuclear
protein (LANP). E4orf6 exports pp32/LANP from the
nucleus to the cytoplasm with its binding partner, HuR,
which binds to an AU-rich element (ARE) present within
many protooncogene and cytokine mRNAs. We found that
ARE-mRNAs, such as 
 
c-fos
 
, 
 
c-myc
 
, and 
 
cyclooxygenase-2
 
,
were also exported to and stabilized in the cytoplasm of
E
 
E4orf6-expressing cells. The oncodomain of E4orf6 was
necessary for both binding to pp32/LANP and effect for
ARE-mRNA. 
 
C-fos
 
 mRNA was exported together with
E4orf6, E1B-55kD, pp32/LANP, and HuR proteins.
Moreover, inhibition of the CRM1-dependent export
pathway failed to block the export of ARE-mRNAs mediated
by E4orf6. Thus, E4orf6 interacts with pp32/LANP to
modulate the fate of ARE-mRNAs by altering the CRM1-
dependent export pathway.
 
Introduction
 
In cells infected with viruses, viral gene products usually ex-
port their mRNA transcripts from the nucleus to the cytoplasm
by using the RNA export machinery of the host cell. Further-
more, several viruses inhibit the export of cellular mRNAs to
maximize the production of their virions. Research into these
viruses has identified essential nuclear RNA export factors
such as CRM1 and TAP (Cullen, 2003a). CRM1 has been
shown as the cellular target for the nuclear export signal (NES)
of human immunodeficiency virus type 1 Rev protein to export
viral mRNAs (Cullen, 2003a). In the case of cellular mRNAs,
although TAP-NXT is usually the crucial nuclear export factor
of the majority of mRNAs (Cullen, 2003b), only a few mRNAs
are exported by the CRM1-mediated pathway. One such mRNA
is an AU-rich element (ARE)–containing mRNA.
ARE is present in the 3
 
 
 
-untranslated regions (UTRs) of
many protooncogenes and cytokine mRNAs (Chen and Shyu,
1995), which target ARE-mRNAs for rapid degradation (Brennan
and Steitz, 2001). HuR, a member of the embryonic lethal
abnormal vision family of RNA-binding proteins (Campos et
al., 1985), binds to ARE to protect ARE-mRNAs from rapid
degradation (Brennan and Steitz, 2001). HuR has been shown
to associate with pp32, APRIL, and SET/TAFI-
 
 
 
 (Brennan et
al., 2000). Under certain conditions, the pp32–HuR complex is
used for the export of ARE-mRNAs from the nucleus to the
cytoplasm in a CRM1-dependent manner (Gallouzi and Steitz,
2001; Gallouzi et al., 2001).
E4orf6 is a protein encoded in the E4 region of the adeno-
virus. It forms a complex with the adenovirus E1B-55kD
(Shenk, 1996). This complex promotes the nuclear export of
viral mRNAs and contributes to the shutoff of cellular mRNAs
during the late phase of adenovirus infection (Shenk, 1996).
E4orf6 shuttles between the nucleus and the cytoplasm (Goodrum
et al., 1996), which is almost certainly essential for the mRNA
transport function of E4orf6. E4orf6 also cooperates with E1A
to transform primary baby rat kidney (BRK) cells, and the
expression of E4orf6 markedly enhances the ability of BRK
and human 293 cells to form tumors in nude mice (Moore et
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al., 1996; Nevels et al., 1997). Although some cellular proteins
were found as E4orf6-associated proteins, only a few of them
were identified.
Here, we show that E4orf6 protein associates with pp32/
leucine-rich acidic nuclear protein (LANP). We found that
E4orf6 exported pp32/LANP and HuR to the cytoplasm and
that ARE-mRNAs were exported and stabilized by E4orf6.
Leptomycin B (LMB), which is an inhibitor of the CRM1-
dependent export pathway, failed to inhibit the export of ARE-
mRNAs when cells expressed E4orf6. These findings indicate
that E4orf6 controls ARE-mRNAs by overcoming the physio-
logical CRM1-dependent export machinery.
 
Results and discussion
 
Isolation of E4orf6-associated proteins
 
To identify the E4orf6-associated proteins (Higashino et al.,
1998), 293 cells were transfected with the expression plasmid of
FLAG-tagged E4orf6. The associated proteins were then isolated
using M2 affinity column chromatography and the acquired pro-
teins were analyzed with MALDI-TOF/MS. Two proteins were
identified as pp32/LANP (Matsuoka et al., 1994; Chen et al.,
1996; Fig. 1 A). We expect that one of these proteins is the phos-
phorylated form of pp32/LANP or APRIL (Mencinger et al.,
1998), which has high similarity to pp32/LANP.
The endogenous interaction of these proteins was con-
firmed with transformed BRK cell lines, which were used to
examine the oncogenic activity of E4orf6 (Moore et al., 1996).
BRK E1 cells were transformed with the adenovirus 
 
E1
 
 (
 
E1A
 
and 
 
E1B
 
) gene and BRK E1
 
 
 
E4 cells were transformed with
 
E1
 
 and 
 
E4orf6
 
 genes, and the only difference among these cells
is expression of E4orf6. E4orf6 was coprecipitated with pp32/
LANP in BRK E1
 
 
 
E4 cells, although the expression level of
pp32/LANP was not changed with the E4orf6 expression (Fig.
1 B, top). Furthermore, reverse immunoprecipitation using
BRK #9 cells, which express E1 and FLAG-E4orf6, showed
the same interaction (Fig. 1 B, bottom).
To detect the region of E4orf6 required for binding, in
vitro interaction was confirmed using a series of deletion mu-
tants of E4orf6 (Fig. 1 C, top) and GST-pp32/LANP. The re-
sults indicated that 85 amino acids of the carboxyl-terminal re-
gion, including the “oncodomain” of the viral gene product
(Nevels et al., 2000), are required for binding (Fig. 1 C, bottom).
The larger molecular mass of dl1-203 is due to the HA tag.
To further confirm the interaction, we observed the sub-
cellular localization of E4orf6 and pp32/LANP. Although
pp32/LANP was located mainly in the nucleus in BRK E1 cells
(Fig. 1 D, top, arrows), it was localized in both the nucleus and
the cytoplasm with E4orf6 in BRK E1
 
 
 
E4 cells (Fig. 1 D,
top). Additionally, pp32/LANP was in the nucleus when cells
expressed E4orf6 dl210-294 (Fig. 1 D, bottom). These data
suggest that E4orf6 has the potential to export pp32/LANP to
the cytoplasm by the use of the oncodomain.
pp32 has also been identified as an associated protein of
E1B-55kD protein (Harada et al., 2002). In that study, as E1B-
55kD failed to interact with pp32 without E4orf6 expression, it
was concluded that E4orf6 is required to induce the assembly
of E1B-55kD with pp32. We agree with this hypothesis, as we
confirmed E4orf6 and pp32/LANP binding without the pres-
ence of E1B-55kD (Fig. 1 C).
 
Export and stabilization of ARE-mRNAs 
by E4orf6
 
We observed the export of HuR protein with its target mRNA
in the presence of E4orf6 using in vivo UV cross-linking. The
results show that HuR protein was exported with its target
mRNA to the cytoplasm in BRK E1
 
 
 
E4 cells, whereas it ex-
isted in the nucleus of BRK E1 cells (Fig. 2 A, left). The
Figure 1. E4orf6 interacts with pp32/LANP. (A) Identification
of pp32/LANP as an associated protein of E4orf6 using 293
cells transfected with expression constructs for FLAG-E4orf6
by M2 (anti-FLAG antibody) affinity column chromatography.
Arrows indicate the proteins identified as FLAG-E4orf6 and
pp32/LANP by MALDI-TOF/MS analysis. (B) The interaction
of E4orf6 with pp32/LANP was confirmed using transformed
BRK cells. The expressions of E4orf6, FLAG-E4orf6, and
pp32/LANP are shown. (C) Schematic diagram of deletion
mutants of E4orf6. NES, nuclear export signal; CCR, conserved
cysteine-rich region; Helix, amphipathic   helix region.
Bar indicates the oncodomain (top). In vitro–translated
E4orf6 mutants were incubated with GST-pp32/LANP, and
the associated E4orf6 mutants were confirmed by immuno-
blotting using the antibody to E4orf6 and HA tag (for dl1-203;
bottom). (D) Subcellular localization of pp32/LANP (a and d)
and E4orf6 (b and e) in mixture of BRK E1 (arrows) and
E1 E4 (top) or BRK dl210-294 (bottom) cells. (c and f) Phase
images are shown. 
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amount of HuR in total extract of each cell was not changed by
E4orf6 (Fig. 2 A, middle) and cell fractionation was confirmed
by immunoblotting (Fig. 2 A, right).
We examined the accumulation of three ARE-mRNAs,
 
c-fos, c-myc
 
, and
 
 cyclooxygenase-2 (COX-2)
 
 mRNAs, in the cy-
toplasm of BRK cells using quantitative real-time RT-PCR. In
the cytoplasm of BRK E1
 
 
 
E4 cells, these mRNAs were sever-
alfold more abundant than those of BRK E1 cells. On the other
hand, the quantity of control 
 
GAPDH
 
 mRNA was almost the
same in both BRK cells (Fig. 2 B, left). The same results were
obtained using 293 cells transfected with E4orf6 expression
construct and HeLa cells infected with wild-type adenovirus
type 5 dl309 (Ad5 dl309) or E4orf6-deficient virus dl355 (Ad5
dl355). As shown in Fig. 2 B (middle and right), all ARE-
mRNAs were accumulated in the cytoplasm of E4orf6-express-
ing cells (Fig. 2 B, E4orf6 and dl309), whereas there was no such
accumulation in control cells (Fig. 2 B, pCMV and dl355). It is
noteworthy that cellular mRNA was accumulated in the cyto-
plasm of wild-type adenovirus-infected cells because usually
cellular mRNAs are shut off in the nucleus by adenovirus in-
fection. Because another ARE-mRNA, 
 
hsp70
 
, has also been
shown to escape the viral export block (Shenk, 1996), ARE-
mRNAs presumably have the potential to be exported even if
almost all cellular mRNAs are shut off. We confirmed that the
transcription of 
 
c-fos
 
 mRNA is not activated by E4orf6 using a
luciferase assay (unpublished data).
The cytoplasmic accumulation was confirmed by North-
ern blot analysis using a luciferase assay system. We con-
structed a pGL3-based luciferase reporter plasmid with the 3
 
 
 
-
UTR of 
 
c-fos
 
 cDNA including the AREs (Fig. 2 C, left). The
amount of the cytoplasmic luciferase mRNA in 293 cells ex-
pressing E4orf6 was much higher than that of control cells
(Fig. 2 C, right). We obtained the same result using BRK cells
(unpublished data).
Because HuR is involved in protecting ARE-mRNA from
degradation in the cytoplasm, E4orf6 may not affect ARE-
mRNA export, but rather facilitate HuR-mediated stabilization.
To address this question, we examined the half-life of ARE-
mRNA of the cytoplasmic fraction. After actinomycin D treat-
ment, the quantity of ARE-mRNAs was measured by quantita-
tive real-time RT-PCR. The half-lives of three ARE-mRNAs in
BRK E1
 
 
 
E4 cells were longer than those of BRK E1 cells, and
furthermore, these cytoplasmic ARE-mRNAs increased 15 or
30 min after treatment even if the product of these mRNAs was
inhibited (Fig. 2 D). These results suggest that mRNAs were
both exported to and stabilized in the cytoplasm.
Export was confirmed by in situ hybridization. In BRK
E1
 
 
 
E4 cells, the majority of 
 
c-fos
 
, 
 
c-myc
 
, and 
 
COX-2
 
 mRNAs
existed in both the cytoplasm and nucleus, whereas these
mRNAs were in the nucleus or perinuclear region of BRK E1
cells (Fig. 2 E, compare a–c with d–f). In BRK dl210-294 cells,
 
Figure 2.
 
E4orf6 exports and stabilizes ARE-mRNAs.
 
 (A) HuR, which
bound to mRNA, was isolated from the nuclear (N) and cytoplasmic (C)
fractions of each BRK cell exposed to UV light by oligo (dT)-cellulose
chromatography (left). The amount of HuR in total extract (TE) of each cell
is shown (middle). The fractions and TE were analyzed by immunoblotting
with antibodies to 
 
 
 
-tubulin and poly(ADP-ribose)polymerase (PARP; right).
(B) The amount of 
 
c-fos, c-myc, COX-2
 
, and 
 
GAPDH
 
 mRNA expressed in
the cytoplasm of each cell was measured by quantitative real-time RT-PCR.
BRK E1 and E1
 
 
 
E4 cells (left), 293 cells transfected with E4orf6 expression
vector (middle), and HeLa cells infected with Ad dl309 and Ad dl355
(right) were used. (C) pCMVGL-ARE, which has ARE of 
 
c-fos
 
 in 3
 
 
 
-UTR of
luciferase cDNA (left), were transfected into 293 cells with or without
E4orf6 expression construct, and then the accumulation of the cytoplasmic
luciferase mRNA was analyzed by Northern blot 24 h after the transfection.
The quantity of 18S RNA of each cell is shown. (D) BRK cells were treated
with actinomycin D and the amount of each cytoplasmic ARE-mRNA was
estimated at the indicated time by quantitative real-time RT-PCR. Data are
mean 
 
  
 
SEM of three independent experiments. (E) The distribution of
ARE-mRNAs was examined in BRK cells. BRK E1
 
 
 
E4 (a–c), E1 (d–f),
dl210-294 (g–i), and NES (
 
 
 
) (j–l) cells were subjected to in situ hybrid-
ization by using digoxigenin-labeled antisense oligonucleotide probes
complementary to 
 
c-fos
 
 (a, d, g, and j), 
 
c-myc
 
 (b, e, h, and k), and 
 
COX-2
 
(c, f, i, and l) mRNAs and rhodamine-conjugated antidigoxigenin anti-
body. DAPI-stained nuclei are shown. (F) ARE-mRNAs associated with HuR
were isolated by RIP analysis using the nuclear (N) and cytoplasmic (C)
fractions of BRK cells. In, 10% input of each fraction; P, pellet; S, supernatant
of immunoprecipitation. 
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which express E4orf6 dl210-294 lacking the oncodomain (Fig.
1 D), these mRNAs were not exported (Fig. 2 E, g–i). On the
other hand, mutation of the NES (Fig. 1 D), which has been
shown as leucine-rich Rev-like NES (Dobbelstein et al., 1997),
did not affect the export (Fig. 2 E, j–l). Together, these results
suggest that ARE-mRNAs are exported to the cytoplasm of
cells expressing E4orf6 and the oncodomain, but not NES, is
critical for the export.
To observe the export of ARE-mRNAs with HuR protein
directly, we performed an RNP immunoprecipitation (RIP) as-
say. As shown in Fig. 2 F, these ARE-mRNAs all existed in the
cytoplasm of BRK E1
 
 
 
E4 cells with HuR protein, whereas
they were only found in the nucleus of BRK E1 cells. These re-
sults indicate that these ARE-mRNAs are exported together
with HuR protein.
 
E4orf6, E1B-55kD, pp32/LANP, and 
HuR are associated with 
 
c-fos
 
 mRNA
 
We performed an RIP assay to observe the interaction be-
tween the protein complex and 
 
c-fos
 
 mRNA. In BRK E1
cells, 
 
c-fos
 
 mRNA was coprecipitated with HuR and pp32/
LANP proteins only in the nuclear fraction. On the other
hand, it was coprecipitated with HuR, pp32/LANP, E4orf6,
and E1B-55kD in both the nuclear and cytoplasmic fractions
of BRK E1
 
 
 
E4 cells (Fig. 3 A). This suggests that these pro-
teins are associated with 
 
c-fos
 
 mRNA and are all exported to
the cytoplasm when cells express E4orf6. Interestingly, E1B-
55kD associated with 
 
c-fos
 
 mRNA in BRK E1
 
 
 
E4 cells, but
not in BRK E1 cells. This finding indicates that E4orf6 is nec-
essary for E1B-55kD to associate with 
 
c-fos
 
 mRNA. This is
the first evidence showing that E4orf6 transports mRNA by
association with its target mRNA.
We examined whether E4orf6 affected pp32/LANP–HuR
binding. Considering coprecipitated HuR with pp32/LANP, the
binding intensity of the pp32/LANP–HuR complex was not al-
tered by the expression of E4orf6 (Fig. 3 B). Furthermore,
E4orf6 was able to interact with HuR in vivo (Fig. 3 C, left),
and in vitro–translated E4orf6 protein bound to GST-HuR (Fig.
3 C, right). These results indicate that E4orf6 interacts with
both pp32/LANP and HuR without disturbing pp32/LANP–
HuR binding.
Additionally, as E4orf6 was able to bind to pp32/LANP
in the presence of RNaseA, this interaction is not mediated by
RNA (Fig. 3 D). Together, we concluded that E4orf6 formed a
protein complex and associated with ARE-mRNA.
Figure 3. E4orf6, E1B-55kD, pp32/LANP, and HuR are associated with
c-fos mRNA. (A) c-fos mRNA coprecipitates in the immunoprecipitation of
HuR, pp32/LANP, E4orf6, and E1B-55kD from the cytoplasmic and nuclear
fractions of each BRK cell. Mouse IgG (mIgG) was used as a control for the
antibodies. (B) Coprecipitated HuR protein in the precipitates of pp32/
LANP-specific antibody was immunoblotted to visualize HuR-pp32/LANP
binding using 293 cells. The expressions of transfected HuR and pp32/
LANP are shown. (C) The same transfected cells were used to observe
in vivo binding between E4orf6 and HuR using the indicated antibodies.
On the bottom are the expression of E4orf6 and HuR (left). In vitro binding
was confirmed using GST-HuR and in vitro translated (IVT) E4orf6 (right).
(D) The interaction between E4orf6 and pp32/LANP was analyzed in the
presence of RNaseA using 293 cells transfected with indicated plasmids.
The expression of pp32/LANP and FLAG-E4orf6 are shown.
Figure 4. E4orf6 exports ARE-mRNA in a CRM1-independent manner.
(A) Coprecipitated CRM1 in the precipitates of pp32/LANP-specific anti-
body was confirmed using 293 cells as described in Fig. 3 B. The expressions
of CRM1, pp32/LANP, and E4orf6 are shown in the bottom three panels.
(B). The quantity of cytoplasmic ARE-mRNAs was measured by quantitative
real-time RT-PCR using heat-shocked (45 C, 1 h) BRK E1 (E1 HS) and BRK
E1 E4 (E1 E4) cells treated with ( ) or without ( ) LMB. Data are mean  
SEM of three independent experiments. (C) The effect of LMB observed
in B was confirmed by RIP analysis using the same cells. Mouse IgG
(mIgG) was used as a control. (D) The effect of LMB for the export of c-fos
mRNA was observed by in situ hybridization using BRK cells as described
in Fig. 2 E. (E) HeLa cells were either treated with heat shock or trans-
fected with E4orf6 expression vector. The cytoplasmic fraction of each cell
was immunoblotted with each antibody in the presence or absence of
LMB. (F) Subcellular localization of E4orf6 in BRK E1 E4 cells in the
presence or absence of LMB. 
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E4orf6 exports ARE-mRNAs by a 
CRM1-independent mechanism
 
It is known that CRM1 binds to pp32/LANP and that ARE-
mRNAs are exported to the cytoplasm in a CRM1-dependent
manner when cells are stimulated by heat shock or serum (Bren-
nan et al., 2000; Gallouzi et al., 2001). To observe the influence
of E4orf6 on pp32/LANP–CRM1 interaction, we examined the
binding intensity of both proteins. Because the quantity of co-
precipitated CRM1 with pp32/LANP was almost the same be-
tween cells with and without E4orf6 expression (Fig. 4 A),
E4orf6 does not disturb the binding of these proteins.
To examine the CRM1 dependence of the export, we esti-
mated the cytoplasmic accumulation of ARE-mRNAs in the
presence of LMB, a specific inhibitor of CRM1 (Kudo et al.,
1998), using heat-shocked BRK E1 cells and BRK E1
 
 
 
E4
cells. In the presence of LMB, the heat shock-mediated accu-
mulation of 
 
c-fos
 
, 
 
c-myc
 
, and 
 
COX-2
 
 mRNAs was inhibited
very efficiently (Fig. 4 B). On the other hand, they still accu-
mulated in the cytoplasm, even if BRK E1
 
 
 
E4 cells were
treated with LMB (Fig. 4 B). The amount of control GAPDH
mRNA was not changed by LMB.
To further confirm these results, the behavior of 
 
c-fos
 
mRNA with HuR, pp32/LANP, and E4orf6 proteins in both
BRK cells was analyzed by RIP assay. 
 
C-fos
 
 mRNA of heat
shock–treated BRK E1 cells was exported to the cytoplasm
with its associated proteins, whereas LMB treatment blocked
this export completely. On the other hand, in BRK E1
 
 
 
E4
cells, 
 
c-fos
 
 mRNA existed in the cytoplasm with the proteins
after inhibition of the CRM1-dependent pathway (Fig. 4 C).
In addition, the CRM1-independent export was con-
firmed by in situ hybridization. 
 
C-fos
 
 mRNA was exported to
the cytoplasm of BRK E1
 
 
 
E4 cells in the presence of LMB,
whereas it was shut off in the nucleus of BRK E1 cells by
LMB (Fig. 4 D). We observed that HuR and pp32/LANP
were exported by E4orf6 in the presence of LMB, although
the heat shock–mediated export of these proteins was blocked
by LMB (Fig. 4 E). The export of E4orf6 in the presence of
LMB was also confirmed by immunofluorescence (Fig. 4 F).
Thus, in cells expressing E4orf6, ARE-mRNAs were ex-
ported to the cytoplasm, even if the cells were treated with
LMB. We conclude that E4orf6 changes the CRM1-depen-
dent ARE-mRNA export pathway.
We present here that the adenovirus E4orf6 interacts with
pp32/LANP to export and stabilize ARE-mRNAs in a CRM1-
independent manner neglecting the physiological conditions of
cellular mRNA export. pp32/LANP has been shown to interact
with the oncodomain of E4orf6, indicating that the control of
ARE-mRNA plays an important role for the oncogenic activity of
E4orf6. We are currently examining the effect of the export and
stabilization of ARE-mRNAs on oncogenic activity of E4orf6.
 
Materials and methods
 
Cells, plasmids, and viruses
 
HeLa, 293, and BRK cells were cultured in DME containing 10% FBS
with antibiotics. BRK E1
 
 
 
E4 cells expressing E1A, E1B, and E4orf6 and
BRK E1 cells expressing E1A and E1B and pcDNA3-Flag-E4orf6 and
pcDNA3-E4orf6 NES (
 
 
 
) have been described previously (Higashino et
al., 1998; Aoyagi et al., 2003). Some cells were treated with heat
shock (45
 
 
 
C, 1 h) or LMB (5 ng/ml). HeLa cells were infected with Ad5
dl309 as wild type or Ad5 dl355, which fails to express E4orf6, at a
multiplicity of 50 PFU per cell. pCMV-E4orf6 dl1-203 containing HA-tag
and Ad5 dl355 were gifts from T. Dobner (Universitat Regensburg, Re-
gensburg, Germany).
Isolation of E4orf6-associated proteins
293 cells were transfected with pcDNA3-Flag-E4orf6 by calcium phosphate–
mediated transfection. After 24 h, the cells were lysed as described previ-
ously (Higashino et al., 1998) and the extract was applied to an M2 (anti-
FLAG antibody) affinity column (Sigma-Aldrich); then, FLAG-E4orf6 was
eluted by FLAG-peptide (Sigma-Aldrich). Mass spectrometry was performed
using a Voyager DE-STR MALDI time-of-flight mass spectrometer (ABI). For in-
terpretation of the mass spectrometry spectra of protein digests, we used the
MS-Fit program available on the website of the University of California, San
Francisco (http://prospector.ucsf.edu/ucsfhtml4.0/msfit.htm).
Protein binding assay
All immunoprecipitation and immunoblotting were performed as de-
scribed previously (Aoyagi et al., 2003). The antibodies used were spe-
cific to E4orf6 (RSA#3; a gift from T. Shenk, Princeton University, Prince-
ton, NJ; Higashino et al., 1998), pp32/LANP (Matsuoka et al., 1994),
HuR (Santa Cruz Biotechnology, Inc.),  -tubulin (Santa Cruz Biotech-
nology, Inc.), PARP (Cell Signaling), CRM1 (BD Biosciences), HA tag
(12CA5; Sigma-Aldrich),  -actin (Sigma-Aldrich), and M2 affinity column.
To examine whether the binding between E4orf6 and pp32/LANP is me-
diated by RNA, immunoprecipitation was performed in the presence of
0.5 mg/ml RNaseA. To observe the in vitro interaction, in vitro–translated
E4orf6 and its mutants were subjected to GST pull down assay using GST-
pp32/LANP or GST-HuR as described previously (Aoyagi et al., 2003).
Immunofluorescence
Immunofluorescence was performed as described previously (Aoyagi et
al., 2003) using antibodies specific to E4orf6 and pp32/LANP followed
by FITC- and rhodamine-conjugated secondary antibodies (Molecular
Probes). Cells were observed using a confocal microscope (model LSM
510; Carl Zeiss MicroImaging, Inc.) equipped with a Plan-Apochromat
63 /1.4 oil objective at RT. Images were imported using the LSM-510
software (Carl Zeiss MicroImaging, Inc.).
UV cross-linking assay
In vivo cross-linking assay was performed as described previously (Pinol-
Roma et al., 1989). In brief, BRK cells were exposed to UV light (6.6  
10
3 ergs/mm
2) for 3 min. Poly (A)
  RNA was then isolated by oligo (dT)-
cellulose chromatography. The eluted poly (A)
  RNAs were treated with
RNase, and cross-linked HuR was detected by immunoblotting.
Quantity analysis of ARE-mRNAs
To examine the quantity of ARE-mRNAs, cells were treated with TRI RE-
AGENT (Sigma-Aldrich), and the RNA was subjected to reverse transcrip-
tion using Rever Tra Ace (TOYOBO). For quantitative real-time RT-PCR
analysis, PCR amplification was performed in DNA Engine Opticon 2 (MJ
Research) with SYBR green PCR master mix (DyNAmo SYBR green qPCR
kit; MJ Research).
RIP assay
RIP assay was performed as described previously (Niranjanakumari et al.,
2002) using anti-HuR, -pp32/LANP, -E4orf6, or –E1B-55kD antibody.
Online supplemental material
Details regarding cells, plasmids, cell fractionation, in situ hybridization,
quantitative real-time RT-PCR, RIP assay, and Northern blot analysis used
for this study are available at http://www.jcb.org/cgi/content/full/
jcb.200405112/DC1.
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